Keryx Biopharma (KERX) Files $250M Mixed Securities Shelf

November 9, 2016 7:29 AM EST
Get Alerts KERX Hot Sheet
Trade KERX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Keryx Biopharma (NASDAQ: KERX) filed a registration with the U.S. SEC to sell up to $250 million of mixed securities.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings

Related Entities

S3

Add Your Comment